Hudson Bay Capital Management
TRAW icon

Hudson Bay Capital Management’s Traws Pharma TRAW Stock Holding History

Hudson Bay Capital Management’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,637
Closed -$232K – 1334
2021
Q4 		$232K Sell
3,637
-2,990
-45% -$240K ﹤0.01% 901
2021
Q3 		$635K Buy
+6,627
New +$854K 0.01% 793

Other funds holding TRAW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hudson Bay Capital Management's TRAW Position: Q1 2022 in Review

Hudson Bay Capital Management sold out of Traws Pharma (TRAW) in Q1 2022, closing a stake of 3,637 shares — an estimated $232K sold.

Hudson Bay Capital Management first reported a position in TRAW in Q3 2021 and held it in 2 quarters. The position peaked at $635K in Q3 2021. 30 funds tracked by Wall St. Rank hold TRAW as of Q1 2022.

  • Hudson Bay Capital Management reported no remaining Traws Pharma position as of Q1 2022 after selling out during the quarter.
  • Hudson Bay Capital Management sold 3,637 Traws Pharma shares in Q1 2022, an estimated $232K.
  • Hudson Bay Capital Management first reported a position in Traws Pharma in Q3 2021 and held it in 2 quarters.
  • Hudson Bay Capital Management's Traws Pharma position peaked at $635K in Q3 2021.
  • 30 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2022.

Based on Hudson Bay Capital Management's 13F filing for Q1 2022, filed 16 May 2022.